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Mice lacking 2 multicopper ferroxidases, hephaestin and
ceruloplasmin, exhibit both tissue iron overload and severe
iron deficiency anemia. These studies reveal the importance
of these proteins and an extra-intestinal role of hephaestin
in ensuring proper systemic iron distribution.
BACKGROUND & AIMS: Multicopper ferroxidases (MCFs)
facilitate intestinal iron absorption and systemic iron recy-
cling, likely by a mechanism involving the oxidization of Fe2þ
from the iron exporter ferroportin 1 for delivery to the
circulating Fe3þ carrier transferrin. Hephaestin (HEPH), the
only MCF known to be expressed in enterocytes, aids in
the basolateral transfer of dietary iron to the blood. Mice
lacking HEPH in the whole body (Heph-/-) or intestine alone
(Hephint/int) exhibit defects in dietary iron absorption but
still survive and grow. Circulating ceruloplasmin (CP) is
the only other known MCF likely to interact with
enterocytes. Our aim was to assess the effects of combined
deletion of HEPH and CP on intestinal iron absorption and
homeostasis in mice.METHODS: Mice lackingbothHEPHandCP (Heph-/-Cp-/-) andmice
with whole-body knockout of CP and intestine-specific deletion of
HEPH (Hephint/intCp-/-) were generated and phenotyped.
RESULTS: Heph-/-Cp-/- mice were severely anemic and had low
serum iron, but they exhibited marked iron loading in duodenal
enterocytes, the liver, heart, pancreas, and other tissues.
Hephint/intCp-/- mice were moderately anemic (similar to Cp-/-
mice) but were iron loaded only in the duodenum and liver, as
in Hephint/int and Cp-/- mice, respectively. Both double knockout
models absorbed iron in radiolabeled intestinal iron absorption
studies, but the iron was inappropriately distributed, with an
abnormally high percentage retained in the liver.
CONCLUSIONS: These studies indicate that HEPH and CP, and
likely MCFs in general, are not essential for intestinal iron absorp-
tion but are required for proper systemic iron distribution. They
also point to important extra-intestinal roles for HEPH in main-
taining whole-body iron homeostasis. (Cell Mol Gastroenterol Hep-
atol 2018;6:405–427; https://doi.org/10.1016/j.jcmgh.2018.06.006)
Keywords: Iron Deficiency Anemia; Iron Overload; Intestinal
Iron Absorption; Non-Transferrin Bound Iron.
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branes and are important for intestinal iron absorption and
systemic iron recycling in vertebrates.1 Evidence suggests
that MCFs oxidize ferrous iron from the iron export protein
ferroportin 1 (FPN1) (also known as SLC40A1), enabling the
iron to bind to the ferric-specific iron carrier in the blood,
transferrin (TF). The MCF ceruloplasmin (CP), which exists
in both a soluble circulating form as well as in a GPI-linked
form, assists in the release of iron from a variety of cell
types including hepatocytes, macrophages, Sertoli cells, and
astrocytes.2–4 The membrane-bound MCF hephaestin
(HEPH) exhibits highest expression in intestinal enterocytes
and aids in the basolateral transfer of dietary iron to the
circulation.5 The primary role of zyklopen (also known as
HEPHL1), the only other known mammalian MCF besides
HEPH and CP, is currently unknown, although its tissue
distribution suggests it could play a role in the brain, retina,
kidney, and testes.6
To determine the importance of MCFs in intestinal iron
absorption, we previously generated mice with whole-body
(Heph-/-) and intestine-specific (Hephint/int) knockout of
HEPH, the only MCF known to be expressed in intestinal
enterocytes.7 Ablation of HEPH perturbed, but did not
abolish, intestinal iron absorption. Young knockout mice
retained iron in their duodenal enterocytes and were anemic,
but their anemia resolvedwith age as body iron requirements
declined. The phenotype was much less severe than that re-
ported for mice with whole-body knockout of FPN1 (unvia-
ble) or tamoxifen-induced postnatal ablation of FPN1 in the
intestine, which results in a near complete block in intestinal
iron absorption and the consequent development of very
severe iron deficiency in young mice.8 The survival and
relatively mild phenotype of Heph-/- mice suggest that
another MCF or some other ferroxidase may be able to
partially compensate for loss of HEPH or, alternatively, that a
ferroxidase is not absolutely required for intestinal iron ab-
sorption. In support of the former hypothesis, several studies
in other cell types have indicated that FPN1 requires a fer-
roxidase to remain on the cell surface and properly export
iron.9–11 In addition, the ferric specificity of the iron carrier
TF suggests a critical role for ferroxidases in the rapid and
specific delivery of iron to this protein.12
The most likely ferroxidase that could at least partially
compensate for HEPH ablation is the circulating form of the
MCF CP. Although Cp is not known to be expressed at the
mRNA level in intestinal enterocytes, CP has been detected by
immunofluorescence in the lamina propria of duodenal villi
and inside enterocytes.13 Most notably, CP has been shown to
augment intestinal iron absorption inmice in cases of extreme
iron need.13 CP also shares a high degree of sequence simi-
larity with HEPH and co-immunoprecipitates with FPN1.5,9
Conversely, zyklopen is not likely to play a role in intestinal
iron absorption because no zyklopen expression has been
detected in the small intestine or in the serum of mice.6To test the potential contribution of CP to intestinal iron
absorption in mice lacking HEPH, we generated mice with
genetic ablation of both ferroxidases (Heph-/-Cp-/-). A mouse
model lacking CP and expressing only the sex-linked anemia
(sla) mutant form of HEPH (Hephsla/slaCp-/-) was previously
reported to be viable and to exhibit a tissue iron-loading
phenotype.14 However, no intestinal iron absorption
studies were reported, and because the sla mutant may be a
hypomorph and not equivalent to a null Heph allele, it was
not possible to use that model to unequivocally determine
whether HEPH and CP together are required for intestinal
iron absorption or, if not, the importance of the role of CP.
To differentiate between phenotypes caused by the ablation
of HEPH in the intestine versus other tissues, we also
generated a mouse model with whole-body knockout of CP
but knockout of HEPH only in the intestine (Hephint/intCp-/-).Results
Heph-/-Cp-/- Mice Are Visibly Small and Severely
Anemic Throughout Life
Heph-/-Cp-/- double knockout (DKO) mice and control
littermates were generated by crossing wild-type (WT),
Heph-/-, Heph-/-Cp-/-, Cpþ/-, and Cp-/- male mice with
Hephþ/-Cp-/- and Hephþ/-Cpþ/- females. Because Heph is
located on the X chromosome, the presence of the Heph
knockout allele in male pups is only dependent on the dam.
Heph-/-Cp-/- pups were viable and could be easily differenti-
ated from their littermates by eye both before weaning
and throughout adulthood because of their small size and
marked pallor (Figure 1A and B). The urine of the Heph-/-Cp-/-
mice, like that of WT mice made severely iron-deficient by an
iron-deficient diet, was clear instead of yellow. In addition,
whereas WT, Heph-/-, and Cp-/- littermates developed yellow
to brown iron deposits on their incisors, the teeth of
Heph-/-Cp-/- mice remained white throughout life (Figure 1C).
Unlike the Heph-/-Cp-/- mice, however, Hephint/intCp-/- mice,
generated by crossing Hephint/intCp-/- males with Hephfl/flCp-/-
females, could not be reliably distinguished by eye from their
2018 HEPH/CP Knockout Disrupts Iron Metabolism 407Hephfl/flCp-/- littermates (although some were noted to have
lighter teeth and paler paws than littermates), suggesting a
milder phenotype (data not shown).
Weights of male Heph-/-Cp-/- mice and non-DKO littermates
were measured from 3–10 weeks of age, and Heph-/-Cp-/- mice
weighed less than their non-DKO littermates, with the differ-
ence becoming significant at 5 weeks of age (Figure 1D).
Heph-/-Cp-/- mice grew more slowly than their non-DKO lit-
termates until approximately 8 weeks of age, when the rates
became similar. On the basis of weights from a smaller sample
of male animals at ages up to 30 weeks, Heph-/-Cp-/- mice
never catch up in weight to controls (data not shown). The
weights of age-matched Heph-/-Cp-/-, Hephint/intCp-/-, and
littermate non-DKO males at 9–11 weeks of age, as well as 16-
to 17-week-old WT mice fed an iron-deficient diet since
weaning, were also compared (Figure 1E). No significant dif-
ferences were detected in the weights of Hephint/intCp-/- mice
and controls, but Heph-/-Cp-/- mice weighed significantly less
than non-DKO mice and were similar in weight to the WT
males with severe diet-induced iron deficiency.
Hematology parameters were examined in male mice at
9–11 weeks of age (Figure 2A, Table 1) and at 20–23 weeks
of age (Table 2). Male mice made severely iron-deficient by
dietary means were also included for comparison. As re-
ported previously, the anemia that affects juvenile Heph-/-
mice was mostly resolved in adults at 9–11 weeks of age,
although Heph-/- mice still had significantly smaller red cells
with lower hemoglobin levels per cell than WT controls.7
Cp-/- mice, as also reported previously, were mildly anemic
at 9–11 weeks of age, with smaller red cells, less hemoglo-
bin, and a lower hematocrit than WT mice.15 At 20–23
weeks of age, results were generally similar to those at 9–11
weeks (Table 2). Hephint/intCp-/- mice were only examined at
9–11 weeks of age and were moderately anemic. They had
significantly smaller red cells, lower hematocrit, less he-
moglobin, and more platelets than WT controls but were not
significantly different from Cp-/- mice except for having a
higher platelet count.
In contrast, at both ages examined, Heph-/-Cp-/- mice had a
very severe hypochromic, microcytic anemia, similar to that
of severely iron-deficient WT mice. They had approximately
one-third the number of red cells of WT mice, and the cells
were significantly smaller than all other genotypes, leading to
a greatly reduced hematocrit. Total hemoglobin levels were
less than one-fourth of that of controls. Because of the much
smaller size of the red cells, the average concentration of
hemoglobin in each cell was not significantly different than
that of controls at 9–11 weeks of age. By 20–23 weeks of age,
however, the average concentration of hemoglobin in each
cell had dropped to levels significantly lower than controls.
No reticulocytes were detected in any Heph-/-Cp-/- mouse
blood examined by the automatic analyzer, indicating that
levels were below the limit of detection and that the mice
possessed little capacity to generate new red cells. Platelet
levels were, on average, more than 10 times that of WT. All
Heph-/-Cp-/- mice examined at 9–11 and 20–23 weeks of age
had grossly enlarged spleens and hearts (data not shown),
similar to observations in mice with diet-induced iron defi-
ciency and consistent with severe anemia. There were nomarked differences in the size of the hearts and spleens of
Hephint/intCp-/- mice compared with controls.
Heph-/-Cp-/- Mice Have Perturbed Tissue
Iron Levels
Heph-/-Cp-/- mouse serum iron levels were 11% of WT
levels (Figure 2B, Table 3). Heph-/-Cp-/- mice had elevated
total iron binding capacities (TIBCs) (approximately twice
that of WT) and TF saturation was 5% of WT. Heph-/- and
Cp-/- single knockout mice also had lower serum iron levels
(71% and 62% of WT levels, respectively) and lower TF
saturations (58% and 59% WT levels, respectively) than
WT.
Non-heme liver iron in 9- to 11-week-old males, as
measured by colorimetric assay, was significantly greater in
Cp-/- and Heph-/-Cp-/- mice than WT controls (2–3 times that
of WT), whereas levels in Heph-/- mice were just less than
half that of WT (Figure 2C). Only 4 Hephint/intCp-/- mouse
livers were available for non-heme liver iron analysis, and
the values varied more than for any other genotype, but the
average iron level was similar to that of Cp-/- and
Heph-/-Cp-/- mice. The expression of liver Hamp1 mRNA was
markedly reduced in both Heph-/- and Heph-/-Cp-/- mice
(4 orders of magnitude versus 3 orders of magnitude lower
than WT, respectively). Notably, Hamp1 mRNA levels in
Heph-/-Cp-/- mice were significantly greater than levels in
Heph-/- mice. Levels in Hephint/intCp-/- and Cp-/- mice were
similar to WT (Figure 2D).
Ferric iron in tissues from 9- to 11-week-old mice was
visualized by using the semi-quantitative Perls’ Prussian blue
histochemicalmethod. Strong iron loadingwas observed in the
supranuclear region of duodenal enterocytes of Heph-/- mice,
especially in cells at the villus tips, as has been reported pre-
viously (Figure 3). Little to no iron was observed in WT con-
trols and Cp-/- enterocytes, but strong deposits were seen in all
Hephint/intCp-/- andHeph-/-Cp-/- samples, consistentwith HEPH
ablation in enterocytes in these mice. In the liver, the results
were generally in agreement with the non-heme liver iron
assay findings, with WT and Heph-/- mice showing the lowest
levels of iron and Cp-/-, Hephint/intCp-/-, and Heph-/-Cp-/- mice
showing greater levels of iron, with the most variation in in-
tensity between Hephint/intCp-/- livers. Staining was most
intense in the periportal regions, withmost of the iron loading
in hepatocytes. The cells proximal to the central veins had little
iron loading. There was no histologic evidence of extra-
medullary erythropoiesis in the liver. Punctate iron deposits
were seen in the spleens of WT and Cp-/- mice and to a much
lesser extent inHeph-/-mice. However, no ironwas apparent in
the spleens of any Hephint/intCp-/- mice or Heph-/-Cp-/- mice.
Consistent with their anemia, the enlarged spleens of the
Heph-/-Cp-/- mice were highly enriched in red pulp and
exhibitedmarked immature erythroid hyperplasia.White pulp
(lymphoid) was negligible.
The Heph-/-Cp-/- mice, but no other mice, showed iron
deposits in the heart, exocrine pancreas, adrenal glands,
kidney, and Brunner’s glands of the duodenum (Figures 3
and 4). In the heart, punctate iron deposits were present
throughout the myocardial tissue, but no clear evidence of
pathology was present at 9–11 weeks of age. In the
Figure 1. General pheno-
type of Heph-/-Cp-/- mice.
Heph-/-Cp-/- mice are pale
and small relative to all
other genotypes exam-
ined. (A) General appear-
ance of 2 adult littermate
mice (Heph-/-Cp-/- on left
and non–double knockout
(non-DKO) on right). (B and
C) Paws of Heph-/-Cp-/-
mice are visibly small and
pale, and their teeth lack
visible iron deposits. (D)
Growth rate of Heph-/-Cp-/-
and non-DKO littermate
(Heph-/-, WT, Cpþ/-, and
Cp-/-) male mice, N ¼ 4–17
mice per age per group
(***P  .001 by t test). (E)
Weights of 9- to 11-week-
old males fed standard
chow and WT 16- to
17-week-old mice fed an
iron-deficient diet since
weaning (Fe def WT),
N ¼ 6–15 mice per geno-
type. For (D) and (E),
data are presented as
mean and SD. Groups with
shared letters are not
significantly different by
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posits of iron in the acinar exocrine cells but no visible
deposits in the islets. Enhanced staining of a few samples
with Perls’ þ 3,30-diaminobenzidine (DAB), however, sug-
gested that iron levels throughout the pancreas, including
the islets, were greater in Heph-/-Cp-/- mice than controls
(data not shown). In Heph-/-Cp-/- adrenal glands, iron
loading was visible in a ring of cells near the outside edge of
the tissue, and in females, on the outside edge but also in a
ring of cells near the medulla/cortical junction (Figure 4).
Iron loading was also uniquely present in the kidney of
Heph-/-Cp-/- mice in some cells of the medulla and cortex.Although there was no gross evidence of pathology in this
tissue at this age, some Heph-/-Cp-/- mice presented with one
necrotic, fluid-filled kidney when euthanized. Abnormal iron
loading was also visible by Perls’ and Perls’ þ DAB staining
in the choroid plexus region of the brains of Heph-/-Cp-/-
mice (data not shown). No marked iron staining was
observed in 9- to 11-week-old mice from any groups in the
skin, jejunum, ileum, lung, tongue, colon, cecum, stomach,
skeletal muscle, gonad, brown fat, or white fat, and females
showed similar overall staining patterns to males, with the
exception of the medulla/cortical junction iron only seen in
female adrenal glands. A small study of tissues (liver,
Figure 2. Hematology and
iron status of
Heph-/-Cp-/- mice. Hema-
tology, serum iron levels,
and hepatic iron concen-
tration were measured in
9- to 11-week-old male
littermates on a chow diet.
(A) Hemoglobin, hemato-
crit, and reticulocytes as
measured by an auto-
mated analyzer, N ¼ 7–14
mice per group. Hematol-
ogy was also measured in
six 16- to 17-week-old WT
mice fed an iron-deficient
diet since weaning (Fe def
WT). (B) Serum iron, TIBC,
and TF saturation as
measured by a colorimetric
ferrozine assay, N ¼ 6–14
mice per genotype. (C)
Hepatic non-heme liver
iron as measured by a
colorimetric assay, N ¼ 4–
7 mice per group. (D)
Liver Hamp1 mRNA
expression normalized to
expression of Hprt mRNA
and then presented as a
proportion of expression
in WT mice. Individual
normalized expression
values (equal to 2-DDCT) for
each mouse are shown on
a log 10 scale, N ¼ 6–8
mice per group. For each
panel, data are presented
as mean and SD, and
groups with at least one
shared letter are not signifi-
cantly different as deter-
mined by Welch t test
corrected for multiple com-
parisons with FDR (FDR-
adjusted P value >.05).
2018 HEPH/CP Knockout Disrupts Iron Metabolism 409pancreas, brown fat, duodenum, jejunum, ileum, lungs,
spleen, and heart) from 20- to 26-week-old WT, Heph-/-,
Cp-/-, and Heph-/-Cp-/- males showed similar results to those
of the 9- to 11-week-old mice, although the iron loading in
the exocrine pancreas of the Heph-/-Cp-/- mice was much
more pronounced at this age.Iron Absorption From the Intestine and Internal
Distribution Is Altered in Heph-/-Cp-/- Mice
Iron absorption and distribution in young adult and
adult male mice. The intestinal absorption of a radio-
labeled dose of iron and the distribution of the doseretained were examined in 2 gavage studies with young
adult (where iron requirements are higher) and adult
(where iron requirements have stabilized) males. The first
gavage study differed from the second in that the mean age
of the mice was lower at the time of dosing (5.6 ± 0.5 weeks
versus 13.1 ± 2.4 weeks). The results of both studies are
presented in Table 4 and are shown graphically in Figure 5
(Study 1 in panels A–C and Study 2 in panels D–F). In these
studies, mice were put on an iron-deficient diet for 1 week
and then dosed by gavage with 59Fe. Radioactive iron was
measured by whole-body counting just after the gavage and
then again 5 days later. In both studies, a greater percentage
of the total 59Fe dose was retained by Heph-/-, Cp
-/-
, and
Table 1.Hematology Parameters of 9- to 11-Week-Old Male Mice
Analysis
Genotype
WT Heph-/- Cp-/- Hephint/int Cp-/- Heph-/-Cp-/- Fe deficient WT
RBC (1012/L) 9.3 ± 0.7a 10.7 ± 1.2b 9.4 ± 1.0a 9.5 ± 1.0a 3.0 ± 0.7c 2.1 ± 0.9c
MCV (fL) 59 ± 2a 54 ± 4b 53 ± 4b,c 47 ± 7c,d 37 ± 2e 43 ± 3d
Hct (%) 55 ± 3a 58 ± 5a 49 ± 4b 45 ± 9b 11 ± 3c 9 ± 4c
Hb (g/L) 143 ± 10a 149 ± 10a 130 ± 10b 117 ± 22b 25 ± 7c 23 ± 8c
MCH (pg) 15.3 ± 0.4a 14.0 ± 0.9b 13.8 ± 0.7b,c 12.3 ± 1.6c,d 8.6 ± 2.0e 11.2 ± 1.6d
MCHC (g/L) 260 ± 11a 258 ± 12a 264 ± 12a 265 ± 12a 234 ± 67a 263 ± 45a
Reticulocytes (109/L) 322 ± 81a 343 ± 81a 313 ± 77a 374 ± 68a None detected 26 ± 22b
Platelets (x109/L) 634 ± 109a 835 ± 182b,c 720 ± 297a,b 1072 ± 325c 6420 ± 1607d 2392 ± 1525c
NOTE. Hematology parameters of 9- to 11-week-old male littermates fed a chow diet and 16- to 17-week-old WT mice fed an
iron-deficient diet since weaning (Fe deficient WT). Mean ± SD. Results for each analysis were examined by Welch t test and
corrected for multiple comparisons with FDR. For each analysis, groups that share at least 1 superscript letter are not
significantly different (FDR-adjusted P value >.05). For each analysis in rows 1–6 and 8, N ¼ 11 WT, 12 Heph-/-, 14 Cp-/-, 7
Hephint/intCp-/-, 13 Heph-/-Cp-/-, and 7 Fe deficient WT mice. For reticulocytes (row 7), N values were the same as for rows 1–6
and 8 with the exception of N ¼ 12 Heph-/-Cp-/- mice (reticulocytes results were not given on the report for 1 mouse) and N ¼ 6
Fe deficient WT mice (1 extreme outlier was excluded).
Hb, hemoglobin; Hct, hematocrit; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; MCV, mean cell
volume; RBC, red blood cells.
410 Fuqua et al Cellular and Molecular Gastroenterology and Hepatology Vol. 6, No. 4Heph-/-Cp-/- mice than by WT mice. Retention in Heph-/- mice
was not significantly different than in WT in Gavage Study 1,
but the power to detect a difference was low because there
were only 3 Heph-/- mice in that study. Heph-/-Cp-/- mice
tended to show greater iron retention than the other
genotypes.
To determine how the iron dose was distributed, the mice
were then euthanized, and the percentage of the retained
dose in the gastrointestinal (GI) tract (esophagus just above
the stomach to the anus, attached mesentery, and intestinal
contents), liver, 200 mL whole blood, kidney, pancreas,
spleen, and in the rest of the carcass (referred to as
“remaining carcass” in this experiment) was examined. In
Gavage Study 1, the pancreas was not excised from the GITable 2.Hematology Parameters of 20- to 23-Week-Old Male
Analysis WT H
RBC (1012/L) 10 ± 0.5a 9.
MCV (fL) 57 ± 3a 5
Hct (%) 57 ± 5a 5
Hb (g/L) 150 ± 8a 13
MCH (pg) 15.0 ± 0.3a 15.
MCHC (g/L) 264 ± 10a 27
Reticulocytes (109/L) 312 ± 36a 36
Platelets (109/L) 657 ± 114a 57
NOTE. Hematology parameters of 20- to 23-week-old males f
examined by Welch t test and corrected for multiple compariso
superscript letter are not significantly different (FDR-adjusted P
mice.
Hb, hemoglobin; Hct, hematocrit; MCH, mean cell hemoglobin;
volume; RBC, red blood cells.tract, so individual results for those 2 tissues are not avail-
able. Clear differences in the distribution of the absorbed iron
were found (Figure 5B and E, Table 4). Of the 59Fe retained in
the whole animal, more iron was in the GI tract in the
Heph-/-Cp-/- mice than any of the other groups, which all had
GI retention similar toWT. The fraction of the retained dose in
the GI tract (not including the pancreas in this case to ensure
that only intestinal iron was assessed) that was in the duo-
denum was measured in Study 2 and was not significantly
different fromWT for any genotype, but the individual results
were highly variable. Of note, after excluding the GI tract from
whole-body iron retention,Heph-/-Cp-/-mice still had retained
more of the iron dose than WT mice (Table 4, “Whole body
retention, minus GI (% of dose)”).Mice
Genotype
eph-/- Cp-/- Heph-/-Cp-/-
2 ± 0.5a 9.7 ± 1.6a 3.4 ± 0.8b
4 ± 1b 47 ± 1c 38 ± 1d
0 ± 3b 45 ± 8b 13 ± 3c
9 ± 6a,b 125 ± 22b 28 ± 11c
0 ± 0.4a 12.8 ± 0.4b 8.0 ± 1.4c
8 ± 8b 275 ± 5b 213 ± 42c
1 ± 79a 349 ± 73a None detected
8 ± 104a 676 ± 110a 6694 ± 1501b
ed a chow diet. Mean ± SD. Results for each analysis were
ns with FDR. For each analysis, groups that share at least 1
value >.05). N ¼ 8 WT, 4 Heph-/-, 7 Cp-/-, and 6 Heph-/-Cp-/-
MCHC, mean cell hemoglobin concentration; MCV, mean cell
Table 3.Serum Iron, TIBC, and TF Saturation
Analysis
Genotype
WT Heph-/- Cp-/- Heph-/-Cp-/- Fe deficient WT
Serum iron (mg/dL) 120 ± 29a 85 ± 13b 74 ± 16b 13 ± 5c 30
TIBC (mg/dL) 379 ± 39a 462 ± 47b 413 ± 27a,b 874 ± 60c 527
TF saturation* (%) 30.3 ± 6.5a 17.6 ± 1.0b 18.0 ± 4.0b 1.5 ± 0.5c 5.7
NOTE. Serum iron, TIBC, and TF saturation as measured by ferrozine colorimetric assay in 9- to 11-week-old male littermates
fed a chow diet and WT mice fed an iron-deficient diet for 6 weeks since weaning (Fe deficient WT). Mean ± SD; if no SD, only
1 animal was tested. Results for each analysis were examined by Welch t test and corrected for multiple comparisons with
FDR. For each analysis, groups that share at least 1 superscript letter are not significantly different (FDR-adjusted P value
>.05). Fe deficient WT mice were not included in the statistical analyses. N ¼ 7 WT, 7 Heph-/-, 14 Cp-/-, and 10 Heph-/-Cp-/-
mice. For TIBC and TF saturation, N ¼ 6 WT, 6 Heph-/-, 13 Cp-/-, and 10 Heph-/-Cp-/- mice.
*TF saturation assumes any iron detected in this assay is bound to TF in vivo.
2018 HEPH/CP Knockout Disrupts Iron Metabolism 411In both studies, a significantly lower percentage of the
retained dose was present in 200 mL of whole blood from
Hephint/intCp-/- and Heph-/-Cp-/- mice than WT, Heph-/-, and
Cp-/- mice. Furthermore, blood 59Fe levels in Heph-/-Cp-/-
mice were much lower than in Hephint/intCp-/- mice. When
red cells and serum were separated, no radiation could be
detected in the serum fraction from any of the mice, indi-
cating that essentially all of the radioactive iron in the blood
was incorporated into red cells. We next estimated the
percentage of the total retained dose that was present in the
total blood volume (the total fraction incorporated into red
blood cells) by assuming that approximately 6% of each
mouse’s total body weight was blood (Figure 5C and F,
Table 4).16 By this method, Heph-/-Cp-/- mice only incorpo-
rated 10% ± 2% and 10% ± 3% of the retained dose into
circulating red cells, whereas WT mice incorporated 72% ±
22% and 68% ± 17%, in Studies 1 and 2, respectively.
Heph-/- and Cp-/- mice incorporated levels similar to WT,
whereas Hephint/intCp-/- mice incorporated 50% ± 12% and
45% ± 10%, in Studies 1 and 2, respectively.
A significantly greater fraction of the retained 59Fe
was present in the livers of Hephint/intCp-/- and Heph-/-Cp-/-
mice than in the livers of WT, Heph-/-, and Cp-/- mice.
Hephint/intCp-/- and Heph-/-Cp-/- mice had similar fractions of
the retained dose in their livers. Tissue weights were
measured in Study 2, and Heph-/-Cp-/-mice had on average a
1.2–1.4 times higher fraction of their body weight in their
livers than the other genotypes (which had similar levels),
but this weight difference could not account for the greater
fraction of retained iron in their livers (Figure 6).
Overall, very little of the radiolabeled iron dose was
detected in the kidneys, spleen, or pancreas of any
mouse, and levels were close to the limit of detection.
However, Heph-/-Cp-/- mice had a significantly greater
fraction of retained iron in their spleen and pancreas
than the other genotypes. The spleens of Heph-/-Cp-/-
mice made up approximately 7 times more of their body
weight than in the other groups, so this may explain the
greater fraction of labeled iron in that tissue (Figure 6).
Pancreas weights were not measured. None of the
groups had significantly different fractions of the labeled
iron in their kidneys, and the percentage of body weightin the kidneys was similar for all genotypes (Figure 6).
The percentage of the retained iron dose in the
remaining carcass was significantly lower in the Hephint/
intCp-/- and Heph-/-Cp-/- mice than WT.
Intestinal Iron Absorption and Distribution in
Suckling Mice
Because Heph-/-Cp-/- mice could be readily distinguished
from their non-DKO littermates before weaning, either in-
testinal iron absorption was impaired and/or iron was
inappropriately distributed during suckling. Iron absorption
was measured in male and female juvenile littermates (15
days old) 4 days after gavage of a radiolabeled iron dose
(Figure 7A and B). The Heph-/-Cp-/- mice (N ¼ 4) were
identified by their pale color, and the non-DKO littermates
(N ¼ 8) contained a mix of Heph knockout, Cp knockout, and
WT alleles. The mice were returned to their mother after
dosing. There was large variation in the amount of iron
retained in the Heph-/-Cp-/- pups, and the amount retained
(60% ± 28%) was not significantly different from littermate
non-DKO controls (85% ± 11%; Figure 7A). However, there
were significant differences in the distribution of the retained
iron inHeph-/-Cp-/- juveniles compared to controls (Figure 7B).
Of the dose retained in Heph-/-Cp-/- pups after 4 days, 23% ±
5% was in the GI tract, 38% ± 7% was in the liver, 2% ± 1%
was in the spleen, and 37%± 2%was in the rest of the carcass.
Of the dose retained in the non-DKO littermates, 5% ± 3%
was in the GI tract, 8%± 6%was in the liver, 1% ± 1%was in
the spleen, and 87% ± 6% was in the rest of the carcass. Like
adult Heph-/-Cp-/- mice, the Heph-/-Cp-/- pups had grossly
enlarged spleens. These results suggest impaired transfer of
iron from the intestine of theHeph-/-Cp-/- juveniles to the body,
as well as abnormal retention of the transferred iron in the
liver, as was observed in adults.
Iron Absorption From a Ligated Duodenal
Gut Segment
The amount of iron taken up and transferred specifically
by the duodenum, as well as the distribution of this iron
after only a short period post-transfer, was determined by
measuring radiolabeled iron absorption from ligated
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Figure 3. (See previous page). Tissue histology and Perls’ Prussian blue iron staining in knockout mice. Representative
photomicrographs are shown for duodenum, spleen, liver, pancreas, heart, kidney, and adrenal gland tissues of male 9- to
11-week-old WT, Heph-/-, Cp-/-, Hephint/intCp-/-, and Heph-/-Cp-/- mice. For each tissue where iron staining (blue) was typically
observed for a given genotype, 1 arrow points to an example in this region. Length of scale bars at bottom left of each image
and original magnification of each image are as follows: duodenum (10 mm, 40), spleen (100 mm, 4), liver (100 mm, 4),
exocrine pancreas (10 mm, 40), heart (20 mm, 20), kidney (100 mm, 4), and adrenal gland periphery (10 mm, 40).
Figure 4. Region-specific iron loading in the pancreas, kidney, duodenum, and adrenal gland of Heph-/-Cp-/- mice. (A)
Perls’ Prussian blue staining of the pancreas of a 26-week-old male Heph-/-Cp-/- mouse showing punctate blue iron deposits in
acinar cells and an absence of deposits in the islet cells (scale bar 10 mm, original magnification 40). (B) Perls’ þ DAB
enhanced staining of the kidney of a 10-week-old male Heph-/-Cp-/- mouse showing iron loading (brown) in some cells in
regions 1 and 2 (left image: scale bar 500 mm, original magnification 2). Higher magnification images (scale bar 50 mm,
original magnification 20) show cells in the cortex (1, top right) and in the medulla (2, bottom right). (C) Perls’ staining of the
duodenum of a 10-week-old male Heph-/-Cp-/- mouse showing iron loading of some cells in regions 1 and 2 (left image: scale
bar 50 mm, original magnification 10). Higher magnification images show punctate iron deposits in duodenal enterocytes near
a villus tip (middle image: scale bar 10 mm, original magnification 40) and in the Brunner’s glands (right image: scale bar 10
mm, original magnification 40). (D) Perls’ staining of an adrenal gland in a 10-week-old female Heph-/-Cp-/- mouse, with blue
iron deposits in some cells in regions 1 and 2 (left image: scale bar 100 mm, original magnification 4). Higher magnification
images show iron deposits in cells near the junction of the cortex and medulla (middle image: scale bar 10 mm, original
magnification 40) and on the adrenal gland periphery (right image: scale bar 10 mm, original magnification 40).
2018 HEPH/CP Knockout Disrupts Iron Metabolism 413
Table 4.Radiolabeled Iron Absorption and Distribution Analysis
Study
Genotype
WT Heph-/- Cp-/- Hephint/intCp-/- Heph-/-Cp-/-
Whole-body retention (% of dose) 1 27 ± 9a 46 ± 8a,b 48 ± 13b,c 33 ± 15a,c 62 ± 9b
2 19 ± 9a 38 ± 14b 35 ± 12b 44 ± 14b,c 62 ± 11c
Whole-body retention, minus GI (% of dose)* 1 25 ± 9a 42 ± 7a,b 45 ± 12b 31 ± 14 a,b 51 ± 8b
2 18 ± 9a 36 ± 13b 34 ± 12b 42 ± 14b 55 ± 9b
Percentage of the retained dose in the GI tract** 1 9 ± 4a 9 ± 2a,b 6 ± 1a 8 ± 3a 18 ± 2b
2 4 ± 3a,b 5 ± 2a 4 ± 2b 4 ± 2a,b 13 ± 0.3c
Percentage of the retained dose in the
GI tract that is in the duodenum*
1 No data No data No data No data No data
2 8 ± 7a,b 6 ± 6b 11 ± 9a,b 15 ± 10b 9 ± 2a,b
Percentage of the retained dose in the pancreas* 1 No data No data No data No data No data
2 1.1 ± 0.9a,b 0.6 ± 0.5a 0.7 ± 0.6a 1.8 ± 1.2b 4.7 ± 0.2c
Percentage of the retained dose in 200 mL of blood 1 12 ± 3a 16 ± 1b 12 ± 2a 9 ± 2c 2 ± 0.5d
2 8 ± 2a 9 ± 1a 9 ± 1a 5 ± 1b 2 ± 0.3c
Percentage of the retained dose in the liver 1 9 ± 4a 16 ± 1b 15 ± 2b 25 ± 7c 30 ± 5c
2 11 ± 3a 9 ± 2a 19 ± 3b 39 ± 18c 35 ± 2c
Percentage of the retained dose in the kidneys 1 3 ± 1a 3 ± 0.4a 3 ± 1a 3 ± 1a 4 ± 1a
2 2 ± 1a 2 ± 1a 2 ± 1a 2 ± 1a 3 ± 0.2b
Percentage of the retained dose in the spleen 1 2 ± 1a,b 1 ± 0.4a,b 1 ± 0.4a 1 ± 1 a 3 ± 1b
2 0.1 ± 0.3a 0.1 ± 0.1a 0.4 ± 0.4b 0.2 ± 0.2a,b 2.5 ± 0.3c
Percentage of the retained dose in
the remaining carcass
1 66 ± 6a 55 ± 1b 63 ± 2a 53 ± 5b 43 ± 2c
2 74 ± 5a 73 ± 3a 66 ± 4b 48 ± 15c 41 ± 2c
Estimated percentage of the retained
dose incorporated into red cells***
1 72 ± 22a 80 ± 4a,b 64 ± 6a,b 50 ± 12b 10 ± 2c
2 68 ± 17a 75 ± 6a 73 ± 7a 45 ± 10b 10 ± 3c
NOTE. Radiolabeled iron absorption and distribution as measured 5 days after dosing by gavage. Male mice were maintained
on an iron-deficient diet from 1 week before gavage until the end of the study. In Study 1, mice were 4–5 weeks old when
started on the iron-deficient diet, and in Study 2, mice were 8–17 weeks old. In Study 1, N ¼ 11 WT, 3 Heph-/-, 7 Cp-/-, 8
Hephint/intCp-/-, and 3 Heph-/-Cp-/- mice. In Study 2, N ¼ 14 WT, 13 Heph-/-, 20 Cp-/-, 14 Hephint/intCp-/-, and 3 Heph-/-Cp-/-
mice. Mean ± SD. Results for whole-body retention and whole-body retention minus GI were examined by analysis of variance
followed by Tukey’s post hoc test in GraphPad Prism, whereas results for other analyses were examined by Welch t test and
corrected for multiple comparisons with FDR. Statistics for Studies 1 and 2 were calculated separately. Most spleen and
pancreas sample measurements in non Heph-/-Cp-/- genotypes were near or below the limit of detection. For each analysis
(row), groups that share at least 1 superscript letter are not significantly different (FDR-adjusted P value >.05).
*In Study 1, the pancreas was not separated from the GI tract, so the percentage of the retained dose in the GI tract includes
the pancreas in Study 1 and excludes it in Study 2.
**In Study 1, the duodenum (defined here as the first 5 cm of small intestine) was not separated from the rest of the GI tract, so
data on duodenal retention are not available.
***The estimated percentage of the retained dose incorporated into red cells was calculated for each mouse by using the
counts in 200 mL of blood. Each mouse was assumed to contain approximately 60 mL of blood for every gram body weight for
these estimates. N ¼ 6 Cp-/- for Study 1 because body weight was missing for 1 mouse.
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administered for 30 minutes via a ligated segment in
anesthetized 8-week-old WT, Heph-/-, and Heph-/-Cp-/- mice
(N ¼ 3 per group) 5 days after they had been put on an iron-
deficient diet. The ligated segment was then excised,
opened, and washed, and the radioactive iron remaining in
the gut segment, the wash solutions, the liver, and the rest of
the carcass was counted. No significant differences between
any of the groups were observed in the fraction of the total
dose retained in the washed duodenal gut segment (data not
shown). In addition, no significant differences were found in
the percentage of the total dose transferred from the gut
segment to the rest of the body (liver and rest of the carcass
combined; Figure 7C). However, Heph-/-Cp-/- mice had a
significantly greater fraction of this transferred iron in the
liver (59% ± 13%) than WT mice (5% ± 3%, Figure 7C).Although the percentage of transferred iron in the liver was
greater in all individual Heph-/- mice (28% ± 19%) than WT
mice, the difference was not statistically significant. In a
separate control experiment performed in the same way,
duodenal iron absorption was compared in 8-week-old
Fpn1int/int mice (N ¼ 3) and WT (Fpn1 floxed) littermates
(N ¼ 3). The Fpn1int/int mice were severely anemic on the
basis of their similar appearance to additional littermates
whose hematology was examined (data not shown). FPN1 is
the only known iron exporter in the intestine; thus if the
ligated gut experimental procedure is performed correctly,
iron transfer into the body should be extremely low
(Figure 7D). As expected, the percentage of the total dose
transferred from the gut segment to the rest of the body was
very low (4% ± 4%) and significantly lower than that of WT
controls (25% ± 4%).
Figure 5. Intestinal iron absorption and iron distribution in young adult and adult male mice. Top right: design of Gavage
Studies 1 and 2. On study day 0, male mice were changed from a standard rodent chow diet to an iron-deficient diet to
stimulate intestinal iron absorption. One week later, mice were gavaged with a dose of radiolabeled iron, and whole-body
radiation was measured. Five days later on study day 12, whole-body radiation was again measured, mice were eutha-
nized, and tissues were collected. Radiation in the tissues was measured and used to quantify the amount of iron absorbed
and how it was distributed. Mice in Gavage Study 1 were 4–5 weeks old, whereas those in Gavage Study 2 were 8–17 weeks
old on study day 0. (A–C) Results from Gavage Study 1. (D–F) Results from Gavage Study 2. (A and D) Percent of the dose
retained in the whole animal 5 days (typically sufficient time for complete turnover of the intestinal epithelium) after gavage is
plotted for each genotype. (B and E) Distribution of the retained iron, expressed as the percentage in each tissue compartment
(100  (counts in tissue/sum of all counts for all tissues)). In Study 1, the pancreas was not excised from the GI tract and was
thus counted as part of the GI tract. (C and F) The estimated percent of the retained dose incorporated into red cells as
calculated for each mouse based on counts in 200 mL of blood. Each mouse was assumed to contain approximately 60 mL of
blood for every gram body weight for these estimates. N ¼ 6 Cp-/- for Study 1 because the body weight was missing for 1
mouse. Data are presented as mean and SD, and groups (panels A, C, D, and F) with at least 1 shared letter are not signif-
icantly different as determined by Welch t test corrected for multiple comparisons with FDR (FDR-adjusted P value >.05).
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Figure 6. Body weight
and relative liver, spleen,
and kidney weights of
animals in Gavage
Study 2. (A) Whole-body
weight and weight of indi-
vidual tissues for each ge-
notype. (B) Percent of total
body weight in each tissue
for each genotype. Data
are presented as mean and
SD. Groups with at least 1
shared letter are not
significantly different as
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Localized to the Basolateral Membrane in
Heph-/-Cp-/- Duodenal Enterocytes
FPN1 expression (normalized to actin) was approxi-
mately 3 times higher in isolated duodenal enterocytes from
adult 10- to 12-week-old male Heph-/- and Heph-/-Cp-/- mice
than it was in WT or Cp-/- mice, which had similar levels
(Figure 8A and B). Immunofluorescence indicated a pri-
marily basolateral localization of FPN1 in duodenal enter-
ocytes of all genotypes examined, with greater expression at
the villus tips. In agreement with the immunoblot results,
signal intensity was greater in the Heph-/- and Heph-/-Cp-/- villi
than in theWT or Cp-/- villi. In addition, FPN1was observed in
cells in the lamina propria of Heph-/- and Heph-/-Cp-/- mice but
not in WT or Cp-/- mice (Figures 8C and 9).
Discussion
Both Heph-/-Cp-/- and Hephint/intCp-/- mice were viable
and able to absorb dietary iron, demonstrating that
HEPH and CP are not absolutely required for intestinaliron absorption. However, study of these mice revealed
that HEPH and CP together are critical for maintaining
normal iron homeostasis in both the intestine and other
tissues.
Although Heph-/-Cp-/- and Hephint/intCp-/- mice survived,
both double knockout strains had a more severe phenotype
than mice lacking HEPH or CP alone. We previously re-
ported that Heph-/- and Hephint/int mice exhibit iron loading
in duodenal enterocytes throughout life and have an anemia
when young that improves with age.7 Iron levels in the
tissues of Heph-/- and Hephint/int mice (with the exception of
duodenal enterocytes) were low, but the phenotype of the
Heph-/- mice was more pronounced than in the mice with
intestine-specific knockout, suggesting that HEPH may play
important roles in tissues other than the intestine.7 On the
other hand, Cp-/- mice have been shown to exhibit pro-
gressive iron loading in the liver (hepatocytes and Kupffer
cells) and spleen (macrophages) and to have a mild anemia
that persists throughout life.15,17 We did not observe iron
loading by Perls’ staining in Kupffer cells in any mice lacking
CP, possibly because we used younger mice than previous
Figure 7. Intestinal iron absorption and iron distribution in suckling mice and in adult mice after absorption from a
ligated duodenal segment. (A) Nursing 15-day-old male and female littermates were dosed by gavage with radiolabeled iron
and then returned to their mother. The percent of the dose retained in the whole animals 4 days after gavage is plotted. (B)
Distribution of the retained iron in (A), expressed as the percentage in each tissue compartment (100  (counts in tissue/sum of
all counts for all tissues)). For this experiment, the blood and the kidneys were not removed and were thus counted as part of
the remaining carcass. Similarly, the pancreas was not excised from the GI tract and was thus counted as part of the GI tract.
(C) A dose of radioactive iron was administered for 30 minutes via a ligated duodenal gut segment in anesthetized 8-week-old
mice (N ¼ 3 per group) 5 days after they had been put on an iron-deficient diet. The ligated gut segment was then excised,
followed by the liver. The fraction of the dose transferred out of the gut segment was calculated as the sum of the counts in the
liver and remaining carcass divided by the sum of the total counts in these tissues as well as in the excised ligated gut
segment. The fraction in the liver was calculated as the counts in the liver divided by the sum of the counts in the liver and
remaining carcass (not including the excised ligated gut segment). (D) In a similar experiment, control Fpn1int/int mice, which
lack the iron transport protein required for basolateral iron export from enterocytes, showed negligible iron transfer from the
ligated segment into the body, as expected. For each panel, the mean and SD are shown for each group. Groups with at least
1 shared letter are not significantly different as determined by Student t test (P value >.05) or Welch t test corrected for multiple
comparisons with FDR (FDR-adjusted P value >.05).
2018 HEPH/CP Knockout Disrupts Iron Metabolism 417studies.17,18 In addition, but not studied here, the HEPH
mutant strain Hephsla/sla, Heph-/-, and Cp-/- mice have all
been reported to have disordered iron metabolism in the
brain.19–21
Here we show that, similar to Heph-/- and Hephint/int
mice, Hephint/intCp-/- mice had iron loading in the
absorptive epithelial cells of the duodenum, suggesting
reduced basolateral export of iron, and very little
observable iron in the spleen by Perls’ staining, sug-
gesting systemic iron deficiency. However, unlike Heph-/-
and Hephint/int mice but consistent with Cp-/- mice, liver
non-heme iron levels were significantly greater inHephint/intCp-/- mice than WT controls. The hematologic
parameters of Hephint/intCp-/- mice suggested that they
generally had less iron available for erythropoiesis than
Heph-/-, Cp-/-, and WT controls. Male Hephint/intCp-/- mice
were not statistically different from Cp-/- mice in any
blood parameters, but they showed a trend toward a
more anemic phenotype than Cp-/- mice.
Heph-/-Cp-/- mice had a much more severe phenotype
than Hephint/intCp-/- mice that was more complex than could
be explained by the simple additive effect of the phenotypes
of Heph-/- and Cp-/- mice. In addition to phenotypes
observed in the Hephint/intCp-/- mice, including iron loading
Figure 8. FPN1 expression and localization in knockout mouse models. (A) FPN1 expression was examined by immu-
noblotting of isolated duodenal enterocyte lysates from adult 10- to 12-week-old male WT, Heph-/-, Cp-/-, and Heph-/-Cp-/-
mice (N ¼ 3 mice per genotype as shown). Duodenal enterocyte lysate from a 15-week-old Fpn1int/int mouse was used as a
negative control for the FPN1 antibody (lane 1). The FPN1 antibody used here gives a non-specific band just above the red
ladder marker. The lane just before the ladder representing a different genotype was removed using Adobe Photoshop (a black
vertical line denotes where this lane was cut out). (B) Densitometry as performed on the immunoblot shown in (A) as well as an
additional immunoblot with lysates from 3 additional WT and 8 additional Heph-/-Cp-/- mice, for a total of 6 WT, 3 Heph-/-, 3
Cp-/-, and 11 Heph-/-Cp-/- mice. FPN1 density was normalized to actin density in each lane, and then all results were
normalized to the WT control group average. Mean and SD are shown. Groups with at least 1 shared letter are not significantly
different as determined by Welch t test corrected for multiple comparisons with FDR (FDR-adjusted P value >.05). (C) FPN1
protein in formalin-fixed paraffin-embedded sections of proximal duodenal villi from adult 10- to 12-week-old male WT,
Heph-/-, Cp-/-, and Heph-/-Cp-/- mice was detected by immunofluorescence. FPN1 is stained red, and DAPI stained nuclei are
in blue. Duodena from 4 WT mice, 5 Heph-/-, 6 Cp-/-, and 3 Heph-/-Cp-/- mice were examined, and representative images are
shown (original 20 magnification with 50 mm scale bars). Images are a composite from the red and blue channels.
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Figure 9. FPN1 immuno-
fluorescence control im-
ages. Blue (DAPI) and red
(anti-FPN1) single channel
images (that were shown
merged in Figure 8) are
shown here for WT,
Heph-/-, Cp-/-, and
Heph-/-Cp-/- genotypes, as
well as from a Fpn1int/int
control mouse. In the last
column, representative
composite red and blue
channel images taken from
slides treated only with
DAPI and secondary anti-
body and no anti-FPN1
are shown. Original 20
magnification, 50 mm scale
bars.
2018 HEPH/CP Knockout Disrupts Iron Metabolism 419in duodenal absorptive epithelial cells and the liver and lack
of iron deposits in the spleen, Heph-/-Cp-/- mice also
exhibited a very severe anemia and marked iron loading insome peripheral tissues, including the pancreas, heart, ad-
renal glands, and, as also reported by collaborators, the
kidneys and eyes.22,23 The iron loading in the peripheral
420 Fuqua et al Cellular and Molecular Gastroenterology and Hepatology Vol. 6, No. 4tissues increased with age, but the anemia did not improve,
suggesting that Heph-/-Cp-/- mice were still able to obtain
iron from the diet but that it was inappropriately distrib-
uted. Liver Hamp1 expression was low in Heph-/-Cp-/- mice,
but despite their much more severe anemia and lower
serum iron, it was not as low as in Heph-/- mice. This may be
due to the high liver iron levels in Heph-/-Cp-/- mice partially
overcoming the suppression of hepcidin production.
Heph-/-Cp-/- mice also had white teeth throughout life (dark
yellow-brown in WT littermates), possibly because of an
iron transport defect in the enamel organ.24 Heph-/-Cp-/-
mice, but not Hephint/intCp-/- mice, died prematurely, typi-
cally between 20 and 30 weeks of age, of unknown cause.
Mice carrying the sla mutation in HEPH on a CP knockout
background (Hephsla/slaCp-/-) have also been reported to
have an iron loading phenotype similar to Heph-/-Cp-/- mice,
and developed neurologic abnormalities (including weakness
and gait changes), and died prematurely.14,25 Hephsla/slaCp-/-
mice also developed iron loading in the eye and degeneration
with similarities to age-related macular degeneration,
although the iron loading in the eye was not as severe as in
Heph-/-Cp-/- mice, suggesting that the Heph-/-Cp-/- phenotype
may in general be more severe.22,26,27
In intestinal iron absorption experiments where mice
were gavaged with a dose of radiolabeled iron and whole-
body retention was measured 5 days later, Heph-/-Cp-/-
mice surprisingly retained similar or higher levels of iron
than controls. Greater than 13% of the retained iron in
Heph-/-Cp-/- mice was in the GI tract, 2–3 times more than
any other genotype. The average life span of duodenal
enterocytes, including the period before complete enter-
ocyte differentiation when dietary iron absorption by these
cells is low, is generally reported to be less than 5 days in
adult mice, so we did not expect to observe such high GI iron
retention in Heph-/-Cp-/- mice.28 There was no significant
difference in the percentage of total GI tract radiolabeled
iron in the duodena of Heph-/-Cp-/- mice compared with the
other genotypes (Table 4), suggesting that the retention was
not due to iron retention in Brunner’s glands, which were
shown by Perls’ stain to be iron loaded in Heph-/-Cp-/- mice
and are only found in the duodenum, or due solely to
retention in enterocytes that had not turned over at the end
of our study period. However, cells further down the in-
testinal tract may have taken up retained radiolabeled iron
from sloughed duodenal cells, and if enterocyte turnover
was modestly delayed, this could increase the amount of
iron remaining in the gut. The large intestine has some ca-
pacity to absorb iron, and iron deficiency and hypoxia have
been shown to upregulate iron transport proteins there.29
We did not observe iron retention in the large intestine by
Perls’ staining in animals fed chow diets, but this method is
not as sensitive as measurements with radioactive iron. GI
iron retention was also observed in juvenile Heph-/-Cp-/-
mice when whole-body and intestinal iron were measured
4 days after dosing.
After subtracting the iron that was retained in the GI
tract of both juvenile and adult Heph-/-Cp-/- mice,
approximately 50% of the total dose was absorbed by
these mice, indicating that Heph-/-Cp-/- mice can stillabsorb significant amounts of iron. Because intestinal
iron absorption depends on both the ability of an animal
to absorb iron (which is impaired in the absence of
HEPH) as well as the drive to absorb iron (which is
increased because of the severe anemia) and these pro-
cesses are interdependent and involve many factors, it is
difficult to compare iron absorption in mouse strains
that show variation in each of these parameters.
Although we did not directly compare iron absorption in
Heph-/-Cp-/- mice with that of WT mice made similarly
severely anemic by prolonged feeding of an iron-
deficient diet, we have previously shown that intestinal
iron absorption in severely iron-deficient WT mice is
typically >70%, with negligible iron retained in the GI
tract.7,30 This suggests that intestinal iron absorption in
Heph-/-Cp-/- mice, while still appreciable, is inappropri-
ately low given their low hepcidin expression and severe
anemia.
In Gavage Studies 1 and 2, Heph-/- mice also surprisingly
absorbed more radiolabeled iron than WT mice, even when
accounting for iron retained in the GI tract (w40% of the
total dose, Table 4). The systemic iron deficiency and ane-
mia in Heph-/- mice before being started on the iron-
deficient study diet would be expected to increase their
drive for intestinal iron absorption over that of WT mice,
which have no block to iron absorption. Thus, Heph-/- mice
likely had a higher drive for iron absorption than WT mice
and may have absorbed more of the iron dose (but less in
relation to their need and drive). In our previously pub-
lished results (with WT and Heph-/- mice of similar age as
those in Gavage Study 2 and under very similar conditions),
we observed decreased whole-body iron dose retention in
Heph-/- mice versus WT controls (Heph-/- ¼ 32% ± 9%;
WT ¼ 54% ± 13%).7 Although intestinal iron absorption by
the Heph-/- mice in both studies was similar, absorption
by the WT mice was nearly 3 times higher in this previously
published study than in Gavage Study 2 (Table 4: Heph-/- ¼
38% ± 14%; WT ¼ 19% ± 9%). It is thus possible that
intestinal iron absorption was more stimulated in the WT
mice in the previous study for unknown reasons that could
include differences in the chow diet before the mice were
put on the study diet or that mice in the previous study
were fasted before dosing.
Although Hephint/intCp-/- and Heph-/-Cp-/- mice were
clearly still able to absorb iron, they exhibited perturbed
systemic distribution of the iron. In both genotypes, a
significantly larger proportion of the absorbed radio-
labeled iron dose was found in the liver, and significantly
less was incorporated into red cells, than in WT controls 5
days after dosing. This finding alone is not surprising
because CP is required for normal rates of iron release
from the liver, and Cp-/- mice also had a greater proportion
of the iron dose in the liver than WT mice.31 However, the
Heph-/-Cp-/- mice, and even more interestingly, Hephint/int
Cp-/- mice, had statistically greater retention of the absor-
bed iron dose in the liver than Cp-/- mice, suggesting that
ablation of HEPH in intestinal enterocytes can also affect
dietary iron retention by the liver. Lending some support
to this, a significantly greater proportion of the retained
2018 HEPH/CP Knockout Disrupts Iron Metabolism 421iron dose was located in the liver of Heph-/- mice than WT
controls in Gavage Study 1.
In addition, distribution defects were observed in the 30-
minute duodenal gut loop absorption experiment with
Heph-/-, Heph-/-Cp-/-, and WT control mice. A significantly
greater proportion of the absorbed iron dose was found in
the livers of Heph-/-Cp-/- mice than in the livers of WT
controls. Heph-/- mice also had a greater fraction of the
absorbed iron dose in the liver in this experiment than WT
mice, but the difference was not statistically significant,
possibly because of the small number of mice examined.
Steady-state non-heme iron levels in the livers of Heph-/-
and Hephint/int mice, as measured by colorimetric assay here
and previously, were significantly lower than in WT con-
trols, making it likely that any extra iron absorbed or
retained by the liver of mice just lacking HEPH is ultimately
redistributed to the rest of the body, but perhaps over a
longer time scale than tested in the gavage and gut loop
experiments.7 In contrast, Cp-/-, Hephint/intCp-/-, and
Heph-/-Cp-/- mice had higher steady-state levels of liver non-
heme iron than WT mice.
One potential explanation for these perturbed iron dis-
tribution observations is that ablation of HEPH in duodenal
enterocytes may prevent all or at least a fraction of the iron
exported from the intestine from binding to TF. As a result,
this iron would enter the portal vein as non-transferrin
bound iron (NTBI). Because the duodenal circulation
travels first to the liver before joining the general circula-
tion, this iron would be rapidly taken up by the liver, which
has a particularly high affinity for NTBI, as demonstrated in
studies of intestinal iron absorption in mice either lacking
TF or with fully saturated TF.32 Eventually, however, this
iron would be released from the liver to be redistributed to
other tissues. In mice with ablation of CP as well, the rate of
iron release from the liver would be decreased, leading to
increased clearance times for iron and increased steady-
state levels of liver iron.
Overall, the peripheral tissue iron loading and the severe
anemia phenotype of Heph-/-Cp-/- mice, especially in contrast
to the phenotype of Hephint/intCp-/- mice, indicate an
important role for extra-intestinal HEPH in systemic iron
metabolism that becomes critical in the absence of CP. Osaki
et al33,34 proposed 2 mechanisms (later supported by evi-
dence) by which CP could facilitate erythropoiesis:
increasing iron binding to TF, and increasing iron release
from stores, and both of these could apply as well to extra-
intestinal HEPH.13,15 Because erythropoiesis is almost
entirely dependent on TF-bound iron, any impairment in the
delivery of iron to TF when HEPH is ablated could exacer-
bate anemia. A potential parallel may be seen in the hypo-
transferrinemic mouse.35 With little or no functional TF,
these mice develop a severe anemia, and circulating NTBI is
rapidly cleared by the liver and other peripheral tissues,
giving a pattern of iron loading similar to that of Heph-/-Cp-/-
mice. However, the spleen in both models is spared, and
hepcidin levels remain neglible.35,36 Direct impairment of
iron efflux from extra-intestinal cells could also be a cause of
the severe anemia and the peripheral iron loading observed
in Heph-/-Cp-/ mice. As has been reported for CP, HEPH maymaintain the rate of iron efflux from some cell types by
decreasing FPN1 turnover.10 However, at least in duodenal
enterocytes, mice lacking HEPH (as shown previously) or
lacking both HEPH and CP exhibited increased FPN1 protein
expression that appeared to be properly localized, suggest-
ing that lack of FPN1 is not responsible for the iron loading
in duodenal enterocytes.7 More detailed studies are needed
to decipher the cause of the severe anemia and tissue iron
loading in the Heph-/-Cp-/- mice and to determine which cell
types are involved.
In summary, intestinal iron absorption can occur in mice
lacking HEPH and CP, but both proteins are required for the
proper systemic distribution of the absorbed iron. Systemic
lack of both proteins leads to a severe anemia coupled with
marked iron overload in various other tissues, leading to
premature death in adulthood. Our results confirm the
importance of HEPH in extra-intestinal tissues for main-
taining whole-body iron metabolism, and they suggest that
lack of HEPH and CP leads to increased NTBI.
Materials and Methods
Ethics Statement
All work performed was in accordance with the National
Institutes of Health (NIH) guidelines, as described in the
Guide for the Care and Use of Laboratory Animals of the
NIH, and with approval from the Office of Laboratory Ani-
mal Care at the University of California, Berkeley, and the
QIMR Berghofer Medical Research Institute Animal Ethics
Committee. In vivo experiments are reported here in
accordance with the ARRIVE guidelines.37 All efforts were
made to minimize animal suffering. All authors had access to
the study data and have reviewed and approved the final
manuscript.
Mouse Models
Mice null for both HEPH and CP (Heph-/-Cp-/-), as well as
WT and single knockout mice for these genes, were gener-
ated from crosses of Heph-/- mice, Cp-/- mice, and their
progeny. The generation and phenotypes of the 2 single
knockout strains have been previously described.7,17 Heph is
located on the X chromosome, but for simplicity, female as
well as male mice hemizygous for the Heph knockout allele
are designated as Heph-/-. Pups from Hephþ/-Cpþ/-,
Hephþ/-Cp-/-, and Hephþ/- females bred with WT, Heph-/-,
Heph-/-Cp-/-, Cpþ/- and Cp-/- males were used in these
studies. Females with homozygous knockout of HEPH were
not used as breeders because their pups are iron deficient
regardless of pup genotype.
Mice with whole-body knockout of CP but deletion of
HEPH only in the intestine (Hephint/intCp-/-) were generated
from crosses of Hephint/int mice, Cp-/- mice, and their prog-
eny. Hephint/int mice are HEPH floxed (C57BL/6-
Hephtm1.1Jdun, referred to here as Hephfl/fl) mice bearing 1
copy of the villin-cre transgene Tg(Vil-cre)997Gum and
have been previously described.7 These mice carry floxed
alleles of Heph and 1 copy of the villin-cre transgene. For
these studies, we used Hephint/intCp-/- and their Hephfl/flCp-/-
littermates lacking the villin-cre transgene that were generated
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Hephfl/flCp-/- mice lacking the villin-cre transgene are
phenotypically Cp-/-, and we included them in our studies as
part of the Cp-/- group.
Tamoxifen-induced FPN1 intestinal knockout mice
(Fpn1int/int) were generated as previously described after
several crosses of Fpn1 floxed mice on a mixed C57BL/6J
and 129/SvEvTac background (provided by Professor
Nancy Andrews at Duke University) with mice bearing the
villin-creERT2 transgene Tg(Vil-Cre/ERT2)23Syr and injec-
tion with tamoxifen.7,8,38 Mice for all studies were on the
C57BL/6J background unless otherwise noted.
Animal Husbandry
Mice were maintained on a standard rodent chow diet
containing approximately 160 mg/kg iron (Norco Stock-
feeds, South Lismore, NSW, Australia) or, for intestinal iron
absorption studies as indicated, an iron-deficient diet made
in-house as described previously.39 Mice fed the iron-
deficient diet and dosed with 59Fe were provided with
deionized water and housed in grid-bottom cages designed
to minimize coprophagia. For some studies where a control
group with iron deficiency anemia was required, mice were
weaned onto the iron-deficient diet and maintained on the
diet until they were studied. All mice were allowed unlim-
ited access to food and water.
Tissue Collection
Micewere euthanized by CO2 gas inhalation or anesthetized
by a single intraperitoneal injection of 44 mg/kg ketamine and
8 mg/kg xylazine in saline. Blood was then collected from the
posterior vena cava and heart. For each mouse, approximately
250 mL of blood was collected into potassium ethyl-
enediaminetetraacetic acid tubes (Terumo Corporation, Tokyo,
Japan; cat #3T-MQK) for whole blood analysis or into 1.5 mL
microfuge tubes without anticoagulant to provide serum. Tis-
sueswere harvested, trimmed to remove connective tissue, and
either immediately snap frozen in liquid nitrogen for future
RNA/protein analyses or incubated in 10% phosphate-
buffered formalin overnight at 25C for future paraffin
embedding. Enterocytes were collected as previously
described.7 For serum samples, blood was allowed to clot,
centrifuged to pellet cells, and then the serumwas removed. An
additional centrifugation stepwas then performed to ensure all
cells were removed, and then the serum was snap frozen.
Polymerase Chain Reaction Genotyping
Mice were routinely genotyped by polymerase chain
reaction (PCR) using DNA obtained from a 1- to 2-mm piece
of the distal tail tip or from a small ear punch sample as
described previously.7 Primers, annealing temperatures,
and expected product sizes are described in Table 5.
Protein and RNA Analyses
A small frozen piece of each tissue was removed from
low temperature storage and disrupted by vigorous shaking
with 1.4-mm ceramic beads as described previously.7 ForRNA preparation, this homogenization step was performed
in ice-cold TRIzol (Invitrogen, Melbourne, VIC, Australia),
and RNA was extracted as per the manufacturer’s in-
structions. Complementary DNA was synthesized by using
oligo(dT) primers and Moloney Murine Leukemia Virus
reverse transcriptase (Invitrogen) as per the manufacturer’s
instructions. Real-time quantitative PCR was performed by
using the LightCycler 480 SYBR Green I Master Mix in an
LC480 machine (Roche, Basel, Switzerland) as per the
manufacturer’s instructions, and the data were analyzed by
calculating the concentration of each sample from its Ct
value by using a standard curve made from pooled sample
complementary DNA as described previously.40 The results
were then normalized to the expression of the housekeeping
gene hypoxanthine guanine phosphoribosyltransferase
(Hprt). All primers (Table 5) were previously validated by
melt-curve analysis, PCR product size analysis, and PCR
product sequencing.
For protein expression analysis by immunoblotting, tis-
sue was homogenized in ice-cold lysis buffer (25 mmol/L
Tris-HCl, pH 7.2, 25 mmol/L NaCl, 0.25% Tween-20, 0.25%
NP-40, 0.1% sodium dodecyl sulfate) with protease in-
hibitors as per the manufacturer’s instructions (Complete
protease inhibitor cocktail tablets, Roche; cat
#11697498001). The homogenized sample was centrifuged
at 16,000g for 30 minutes at 4C to pellet debris, and the
supernatant was then collected and assayed for protein
concentration by using the Pierce BCA Protein Assay Kit
(Thermo Fisher Scientific, Rockford, IL). Total protein
(60–80 mg) was mixed with sodium dodecyl sulfate loading
buffer with fresh dithiothreitol. The samples were separated
on 10% Tris-glycine sodium dodecyl sulfate polyacrylamide
denaturing gels and then transferred to Immobilon-FL
polyvinyl difluoride membranes (Merck, Kilsyth, Australia).
Membranes were blocked for 1 hour at room temperature
with shaking in blocking buffer (10% non-fat milk in Tris-
buffered saline with 0.1% Tween-20 [TBST]). Membranes
were then incubated with the relevant primary antibody
(mouse monoclonal anti-beta actin antibody, 1:10,000
dilution, cat #ab6276; Abcam, Cambridge, UK, or rabbit
polyclonal anti-FPN1 antibody EB941,42, 1:500 dilution)
diluted in blocking buffer for 1 hour at room temperature.
The membranes were then washed with TBST and incu-
bated for 1 hour at room temperature with secondary
antibody (goat anti-rabbit horseradish peroxidase, 1:8000
dilution; Invitrogen, cat #65-6120, or goat anti-mouse
horseradish peroxidase, 1:10,000 dilution; Invitrogen, cat
#62-6520). The blots were washed in TBST and imaged on
film or in a digital imager (LAS500; GE Healthcare, Little
Chalfont, United Kingdom) after incubation with the West-
ern Lightning Plus-ECL Kit solutions (Perkin-Elmer, Glen
Waverley, VIC, Australia). Densitometry was performed by
using the TotalLab Quant software (Newcastle upon Tyne,
United Kingdom). For each sample, results for the protein of
interest were normalized to that of actin. The results for
each mouse group were then averaged and normalized to
the average result for the WT control group for data
presentation.
Table 5.Primers
Gene Primer Name Primer sequence Anneal Temperature (C) Expected products






55 240 bp ¼ WT allele present;
300 bp ¼ Heph floxed allele present








55 320 bp ¼ reaction successful;











64 200 bp ¼ reaction successful;
1100 bp ¼ villin-cre transgene present











64 1000 bp band ¼ Cp knockout allele present




55 260 bp ¼ Villin-creERT2 transgene present




58 130 bp product




58 78 bp product
NOTE. The sequences of the starred (*) primers are from The Jackson Laboratory website, www.jax.org.
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Iron Measurements
Paraffin-blocked tissues were sectioned and stained for
ferric iron using Perls’ Prussian blue stain with or without
enhancement with DAB by the Histotechnology Facility at
QIMR Berghofer.43 In brief, tissues were submitted to the
Facility in 70% ethanol after overnight incubation at room
temperature in phosphate-buffered saline (PBS) solution
with 10% formalin. Tissues were dehydrated in ethanol,
cleared with xylene, and then embedded in paraffin. Sec-
tions 4 mm in thickness were cut, mounted on slides, and
then deparaffinized. After rehydration in deionized water,
the sections were incubated for 15–30 minutes in an equal
volume mixture of 4% hydrochloric acid (HCl) and freshly
prepared 4% aqueous potassium ferrocyanide. Sections
were washed in distilled water and then counterstained
with nuclear fast red for 10 minutes. The slides were then
washed, dehydrated, and mounted. Slides were scanned
using an Aperio ScanScope (Leica Biosystems, Wetzlar,
Germany) AT2 light microscope on the 40 magnification
setting. For colorimetric non-heme iron quantification, a
modification of the Torrance and Bothwell method was used
as described previously.7
Immunofluorescence
Tissue sections (4 mm) were cut from paraffin-blocked
duodena and mounted on glass slides, dewaxed with
xylene, and then rehydrated with a series of alcohols. For
antigen retrieval, sections were incubated in 10 mmol/L
citrate buffer pH 6.0 containing 0.05% Tween-20, heated to
boiling, and maintained at 95C for 20 minutes. Sections
were then incubated in 50 mmol/L glycine/NH4Cl for 15
minutes at room temperature to prevent endogenous fluo-
rescence, blocked for 1 hour at room temperature with 10%
fluorescence dilution buffer (1 mmol/L CaCl2, 1 mmol/L
MgCl2, 5% goat serum, 5% fetal bovine serum, 2% bovine
serum albumin, PBS), and incubated with FPN1 rabbit
polyclonal primary antibody EB9 (1/500 dilution) overnight
at 4C. Subsequent to washing with PBS, the sections were
incubated with secondary antibody (Molecular Probes goat
anti-rabbit Alexa Fluor A594; Life Technologies, Carlsbad,
CA; cat #A-11012, 1/500 dilution) for 30 minutes, washed
with PBS, and incubated with DAPI counterstain for 5 mi-
nutes at room temperature. After further PBS washes, the
sections were mounted in Prolong Gold antifade mountant
(Life Technologies). Sections were viewed with a Zeiss
LSM780 with AxioObserver confocal microscope with a
Plan-Apochromat 20/0.8 M27 objective, and images were
acquired and analyzed using the Zeiss Zen software.
Blood Analyses
The anticoagulated blood samples in ethyl-
enediaminetetraacetic acid were analyzed at the Pathology
Department of the Royal Brisbane and Women’s Hospital
(Brisbane, Australia) using a Sysmex XE-5000 automated
hematology analyzer (Roche Diagnostics, Castle Hill, NSW,
Australia). Serum iron, TIBC, and TF saturation were
measured by using the ferrozine-based Iron/TIBC ReagentSet (Pointe Scientific Inc, Canton, MI). These assays were
performed per the manufacturer’s instructions, but they
were scaled down linearly by a factor of 20 and performed
in a 96-well plate, as previously described.30 Analyses were
performed on samples of serum that had undergone a single
freeze-thaw cycle.Intestinal Iron Absorption Assays
Intestinal iron absorption was studied either by dosing
by gavage, as described previously, or by dosing via an
isolated duodenal gut segment.7 The mice were not fasted
before or after the dosing to avoid additional stress on the
Heph-/-Cp-/- mice.
Gavage studies in young adult (Study 1) and adult
(Study 2) mice. At a mean age of 5.6 ± 0.5 weeks (Study
1) or 13.1 ± 2.4 weeks (Study 2), male mice initially
maintained on a chow diet were switched to an iron-
deficient diet to stimulate iron absorption. After 1 week
on the diet, the mice were dosed by gavage with 100 mL of a
freshly prepared solution containing 200 mmol/L ferrous
sulfate in 10 mmol/L HCl, spiked withw3 mCi 59Fe as ferric
chloride (Perkin-Elmer, Waltham, MA; cat #NEZ037001MC)
per dose. In Study 1, the mice were dosed in 3 groups over
2 days in the 10:00 AM to 3:00 PM window. In Study 2, the
mice were dosed in 4 groups over 2 days between 11:00 AM
and 2:00 PM. The radiation in each mouse was measured by
using a RAM DA gamma counter with a PM-11 tube (Rotem
Industries, Arava, Israel) at a fixed distance just after dosing
and then again 5 days later. By this time, any iron not
absorbed by intestinal enterocytes should have cleared from
the mouse, and there should be complete turnover of the
intestinal epithelium. However, this period of time is not
long enough for substantial iron excretion to occur. On the
basis of the findings of Stevens et al44 and our own data on
biliary and urinary iron excretion (Lu et al, unpublished),
we estimate total excretion to be no more than 2.5% of body
iron during this period.23 After subtraction of the back-
ground counts, the percentage of the initial dose remaining
in each mouse was calculated.
Mice were then euthanized by ketamine/xylazine/saline
as described above. They were then weighed, and the body
cavity was opened on a small sheet of plastic-backed
absorbent material (Benchkote; Whatman, Maidstone,
United Kingdom). Blood was collected from the posterior
vena cava, and 200 mL was immediately aliquoted into a
separate tube. The GI tract, comprising the lower esophagus
just proximal to the stomach down to the anus and
including the pancreas, connective tissue, and any contents
inside the GI tract, was then excised. In Study 2, but not in
Study 1, the pancreas was cut away from the GI tract and
wrapped in foil, and the first 5 cm of small intestine was
excised from the GI tract and wrapped in a piece of foil, to
later measure the radiolabeled iron in the pancreas and
duodenum, respectively. The remaining GI tract was placed
in a 10 mL tube. The spleen, liver, and kidneys were then
excised from the carcass, weighed on a microscale, and
wrapped in foil (1 tissue per foil packet). Any blood on the
dissection instruments was wiped on the Benchkote. The
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collect blood were wrapped together in the Benchkote and
placed in a 50 mL tube and labeled “remaining carcass”.
After clotting, the 200 mL blood samples from Study 2 were
centrifuged to separate serum from the red cell pellet to
later determine the radioactivity in each fraction separately.
The spleen, liver, kidneys, pancreas, and duodenum were
placed in an oven at 110C and allowed to dry overnight,
and the remaining carcass, GI tract, and the 200 mL blood
sample (or separated serum and red cell samples, for Study
2) were frozen at –20C. The next day, the radioactivity in
the liver, kidney, spleen, pancreas, 200 mL blood, duodenum,
GI tract, and remaining carcass was measured separately at
a fixed distance from the gamma counter. After background
subtraction, the percentage of radiation in each tissue
relative to the total in the whole animal was calculated by
dividing the counts in a particular tissue by the sum of
counts in all the tissues and then multiplying by 100. Values
near the limit of detection that were below 0 after back-
ground subtraction (primarily for the spleen) were assigned
a value of 0.
In addition, an estimation of the proportion of radioac-
tivity in each animal’s total blood volume was calculated.
The total blood volume of each mouse in microliters was
first estimated by multiplying the weight of the mouse in
grams by 60 (assuming approximately 60 mL blood per
gram of mouse body weight).16 The estimated total blood
volume was then multiplied by the counts per microliter of
blood (minus background) in the 200 mL blood sample. The
estimated total counts in the blood were then divided by the
total counts retained in the mouse (minus background), and
then the result was multiplied by 100 to give the estimate of
the percentage of the radioactivity in the blood.
Gavage study in suckling mice. Suckling mice were
housed with their mothers, who were maintained on a chow
diet. At 11 days of age, male and female juvenile littermates
were gavaged together in 1 batch with radiolabeled iron,
and the total dose was counted as described above. Four
days after the gavage, the total dose retained was measured,
and then the mice were euthanized by ketamine/xylazine/
saline intraperitoneal injection as described under “Tissue
collection”. The liver, spleen, and GI tract, comprising the
lower esophagus just proximal to the stomach down to the
anus and including the pancreas, connective tissue, and any
contents inside the GI tract, were excised. The radioactivity
in the liver, spleen, GI tract, and remaining carcass was
measured separately at a fixed distance from the gamma
counter. After background subtraction, the percentage of
radiation in each tissue relative to the total in the whole
animal was calculated by dividing the counts in a particular
tissue by the sum of counts in all the tissues and then
multiplying by 100.
Isolated duodenal gut loop studies. In experiments
where iron absorption was studied by dosing via an isolated
duodenal gut loop, a procedure that has been previously
described in experiments with rats was used and modified
slightly for mice.45 In brief, a mouse was placed in an in-
duction chamber and anesthetized by inhalation of 2.5%
isoflurane in oxygen, delivered at a flow rate of 2 L/min byusing a veterinary anesthetic machine (The Stinger;
Advanced Anaesthesia Specialists, Gladesville, NSW,
Australia). The mouse was then removed from the chamber
and placed ventral side up on a prewarmed (37C) heating
pad covered with 2 layers of Benchkote (one piece large
enough to cover the whole heating pad and another piece on
top just larger than the mouse). The nose and mouth of the
mouse were immediately placed inside a nose cone that was
connected to a continuous flow of 1 L/min oxygen with
1.5% isoflurane anesthetic. Mice were monitored
throughout the whole experiment to ensure adequate depth
of anesthesia.
After ensuring the mouse was unresponsive to paw
pinch, a midline incision was made in the abdomen. The
duodenum was exposed, and 3 loose ligatures were placed
around it, with care taken to avoid positioning that could
impair blood flow once the ligatures were tied. Two of the
ligatures were placed approximately 0.5 cm distal to the
pylorus and one at the ligament of Treitz. A small incision
was made just proximal to the uppermost ligature, a cannula
was inserted, and the upper ligature was tied to secure the
cannula. A second incision was then made just distal to the
lowest ligature. The duodenal segment was flushed with 5
mL saline solution (prewarmed to 37C) via the cannula,
and then the lower ligature was tightened. The duodenal
segment was then infused with 100 mL of a freshly prepared
solution containing 200 mmol/L ferrous sulfate in 10 mmol/L
HCl and spiked with w3 mCi 59Fe as ferric chloride (Perkin-
Elmer; cat # NEZ037001MC) per dose. Next, the second
ligature at the proximal end of the segment was tied off, and
the cannula was removed. The abdomen of the animal was
then covered with warm, damp gauze to prevent drying.
Thirty minutes after the iron dose was administered,
the duodenal segment was carefully excised and placed on
a separate small piece of Benchkote (the Benchkote piece
was checked later by counting to ensure that the duodenal
gut segment had not leaked). The animal was then eutha-
nized by cervical dislocation. The duodenal segment was
cut across at both ends and washed extensively with 20 mL
saline. The wash solutions were recovered and saved for
analysis. Any attached pancreas and mesentery were
carefully trimmed from the exterior of the duodenal
segment and placed on the Benchkote with the rest of the
carcass. The duodenal segment was wrapped in a piece of
foil. The whole liver was then excised from the carcass and
wrapped in a separate piece of foil. The rest of the carcass
was then wrapped in the Benchkote piece beneath it and
placed in a 50 mL tube.
The radioactivity in the wash solution, the duodenal
segment, the liver, and the remaining carcass was counted
by using a RAM DA Gamma Counter with a PM-11 tube at a
distance of 10 cm, and background was subtracted. The total
59Fe dose (total counts) was calculated as the sum of the
counts in the wash, gut segment, liver, and remaining
carcass. The percentage of the total dose retained in the gut
segment was calculated by dividing the counts in the gut
segment by the total counts and multiplying by 100. The
transferred dose was defined as the total number of counts
in the liver and remaining carcass, ie, the iron that had been
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The percentage of the transferred dose in the liver was
calculated by dividing the counts in the liver by the sum of
the counts in the liver and the remaining carcass and then
multiplying by 100.
Statistics
All values are expressed as mean ± standard deviation
(SD). For comparisons between 2 groups, Student t test and
the F test for equal sample variance were performed in
GraphPad Prism (Sunnyvale, CA) version 6.0c for Mac OS X.
For comparisons among multiple groups, Welch t test fol-
lowed by false discovery rate (FDR) correction for multiple
comparisons was performed by using the stats package in R.
We applied .05 as the cutoff for P values and FDR-adjusted P
values; the null hypotheses were tested against two-sided
alternatives and rejected if the P value or FDR-adjusted P
value was less than .05.References
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